Us Bancorp \De\ Pmv Pharmaceuticals, Inc. Transaction History

Us Bancorp \De\

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$4.77 - $9.16 $1,144 - $2,198	-240 Reduced 39.34%	370 $1,000
Q4 2022 Feb 13, 2023	SELL	$8.17 - $12.95 $3,619 - $5,736	-443 Reduced 42.07%	610 $5,000
Q3 2022 Oct 27, 2022	BUY	$11.4 - $17.18 $8,664 - $13,056	760 Added 259.39%	1,053 $13,000
Q2 2022 Aug 01, 2022	SELL	$9.23 - $22.43 $15,903 - $38,646	-1,723 Reduced 85.47%	293 $4,000
Q1 2022 May 11, 2022	BUY	$14.86 - $23.55 $28,843 - $45,710	1,941 Added 2588.0%	2,016 $42,000
Q4 2021 Feb 11, 2022	BUY	$19.99 - $30.24 $1,499 - $2,268	75 New	75 $2,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.